Work

Author response: Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma

Year: 2018

Type: peer-review

DOI: 10.7554/elife.41305.044

Authors: Gerard L Brien, David Remillard, Junwei Shi, Matthew L Hemming, Jonathon Chabon, Kieran Wynne, Eugène T Dillon, Gerard Cagney, Guido Van Mierlo, Marijke P Baltissen, Michiel Vermeulen, Jun Qi, Stefan Fröhling, Nathanael S Gray, James E Bradner, Christopher R Vakoc, Scott A Armstrong

Institutions: Boston Children's Hospital, Harvard University, Trinity College Dublin, Dana-Farber Cancer Institute, Abramson Cancer Center, University of Pennsylvania, University College Dublin, Radboud University Nijmegen, Radboud Institute for Molecular Life Sciences, Oncode Institute, German Cancer Research Center, Heidelberg University, University Hospital Heidelberg, National Center for Tumor Diseases, Deutsches Konsortium für Translationale Krebsforschung, Cold Spring Harbor Laboratory

Language: English

Topic: Protein Degradation and Inhibitors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W2987656807

Cites:

Cited by: 6

Related to: 10